Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: Antagonists for the AGRP/melanocortin receptor binding

被引：37
|
作者：
Arasasingham, PN
Fotsch, C
Ouyang, X
Norman, MH
Kelly, MG
Stark, KL
Karbon, B
Hale, C
Baumgartner, JW
Zambrano, M
Cheetham, J
Tamayo, NA
机构：
[1] Amgen Inc, Dept Small Molecule Drug Discovery, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 01期
关键词：
D O I：
10.1021/jm0255522
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin action.(1) In the hypothalamus, melanocortin peptide agonists act as satiety-inducing factors that mediate their action through the melanocortin-4 receptor (MC4R) whereas AGRP is an opposing orexigenic agent. Novel inhibitors of the AGRP/MC4 binding based on (piperazinylethyl)piperazines were prepared, and their structure-activity relationship was established.
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [1] SAR of (1-aryl-2-piperazinylethyl)piperazines and substituted indoles: Antagonists for the AGRP/melanocortin receptor binding.
    Arasasingham, P
    Fotsch, C
    Jenkins, T
    Lee, T
    Kincaid, JF
    Bo, YX
    Ouyang, X
    Norman, MH
    Kelly, MJ
    Stark, KL
    Karbon, B
    Hale, C
    Baumgartner, JW
    Zambrano, M
    Tamayo, NA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U643 - U644
  • [2] Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor
    Nozawa, Dai
    Okubo, Taketoshi
    Ishii, Takaaki
    Kakinuma, Hiroyuki
    Chaki, Shigeyuki
    Okuyama, Shigeru
    Nakazato, Atsuro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (05) : 1989 - 2005
  • [3] Structure-activity relationship studies of a novel AGRP-melanocortin chimeric template
    Wilson, KR
    Wilczynski, A
    Scott, JW
    Bauzo, RM
    Haskell-Luevano, C
    BIOPOLYMERS, 2005, 80 (04) : 505 - 505
  • [4] Structure-activity relationship studies of a novel AGRP-melanocortin chimeric template
    Wilson, Krista R.
    Wilczynski, Andrzej M.
    Scott, Joseph W.
    Bauzo, Rayna M.
    Haskell-Luevano, Carrie
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 521 - +
  • [5] Studies on the structure-activity relationship of the basic amine of phenylpiperazines as melanocortin-4 receptor antagonists
    Tran, Joe A.
    Arellano, Melissa
    Fleck, Beth A.
    Pontillo, Joseph
    Marinkovic, Dragan
    Tucci, Fabio C.
    Wen, Jenny
    Saunders, John
    Chen, Chen
    MEDICINAL CHEMISTRY, 2008, 4 (01) : 67 - 74
  • [6] Structure-activity relationship of ACTH(148) fragment at the melanocortin-2 receptor
    Habi, A.
    Delhanty, P.
    van de Zande, B.
    van Kerkwijk, A.
    van der lely, A. J.
    Peri, K. G.
    BIOPOLYMERS, 2007, 88 (04) : 619 - 619
  • [7] Structure-activity relationship study on α1 adrenergic receptor antagonists from beer
    Wakimoto, Toshiyuki
    Nitta, Makoto
    Kasahara, Kana
    Chiba, Taketo
    Ye Yiping
    Tsuji, Kuniro
    Kan, Toshiyuki
    Nukaya, Haruo
    Ishiguro, Masaji
    Koike, Minako
    Yokoo, Yoshiaki
    Suwa, Yoshihide
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5905 - 5908
  • [8] Study on quantitative structure-activity relationship of EP1 receptor antagonists
    Yan, Yu-Lian
    Li, Yan
    Yang, Yin-Feng
    Lu, Xiao-Wei
    Zhang, Shu-Wei
    Harbin Gongye Daxue Xuebao/Journal of Harbin Institute of Technology, 2012, 44 (04): : 121 - 125
  • [9] Synthesis and structure-activity relationship of trimethoxybenzyl piperazines: Novel dopamine D4 antagonists
    Purchase, TS
    Glase, SA
    Akunne, HC
    Heffner, TG
    MacKenzie, RG
    Pugsley, TA
    Wise, LD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 184 - MEDI
  • [10] Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonists
    Vos, TJ
    Balani, S
    Blackburn, C
    Chau, RW
    Danca, MD
    Drabic, SV
    Farrer, CA
    Patane, MA
    Stroud, SG
    Yowe, DL
    Claiborne, CF
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2302 - 2305
12345